A Phase II Evaluation of Brivanib in the Treatment of Persistent Or Recurrent Carcinoma of the Cervix: An NRG Oncology/Gynecologic Oncology Group Study

No Thumbnail Available

Authors

Chan, John K.
Deng, Wei
Higgins, Robert V.
Tewari, Krishnansu S.
Bonebrake, Albert J.
Hicks, Michael
Gaillard, Stephanie
Ramirez, Pedro T.
Chafe, Weldon
Monk, Bradley J.
Show 1 more

Issue Date

2017

Volume

146

Issue

3

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Chan, John K.; Deng, Wei; Higgins, Robert V.; Tewari, Krishnansu S.; Bonebrake, Albert J.; Hicks, Michael, et al. (2017). A Phase II Evaluation of Brivanib in the Treatment of Persistent Or Recurrent Carcinoma of the Cervix: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol, September 2017, 146(3):554-559. doi: http://dx.doi.org/10.1016/j.ygyno.2017.05.033

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/115146

PubMed ID

DOI

Identifier

Additional link

http://doi.org/10.1016/j.ygyno.2017.05.033

ISSN

0090-8258

EISSN

Collections